FORT COLLINS, Colo. — KromaTiD, Inc. announced today that it has joined the National Institute of Standards and Technology Genome Editing Consortium, a newly launched public/private partnership (https://www.nist.gov/programs-projects/nist-genome-editing-consortium). The Consortium supports the emerging gene editing market and regulatory agency needs for standardized measurements of gene edits, editing by-products and the risks of utilizing genome editing technologies in research, […]

Ensures validity and reliability of data from cell culture-based research MANASSAS, Va. — ATCC, the premier global biological materials resource and standards organization and the leading supplier of authenticated cells and advanced cell models, today announced the availability of its new PCR-based service to detect mycoplasma contamination in cell cultures. This growing service portfolio is […]

PALO ALTO, Calif.–Science Exchange, the leading marketplace for outsourced R&D™, announces a collaboration with LI-COR Biosciences to offer a suite of molecular imaging services based on LI-COR’s pioneer work in near-infrared fluorescence as a detection method. Based in Lincoln, Nebraska, LI-COR Biosciences is a world leader in innovative imaging systems for proteomics and pre-clinical research. With […]

Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) has established a new subsidiary in Egypt and will begin conducting direct sales and services with the aim of expanding its business in the Middle East. In recent years, Egypt has been setting up healthcare infrastructure in line with the country’s economic expansion and population […]

Knockout Validation of Antibodies Confirms Specificity and Ensures Reproducible Results MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH), a family of brands with a unique and leading portfolio of antibody-based reagents for life science and clinical research, has been validating an extensive and growing number of antibodies using recent advances in gene editing technology. The specificity and power […]

CARLSBAD, Calif. — International Stem Cell Corporation (OTCQB:ISCO) (“ISCO” or “the Company”), a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products, announced today that its wholly owned subsidiary, Lifeline Cell Technology (LCT), has expanded its business and manufacturing capabilities to fulfill current and forecasted demand. LCT has demonstrated stable manufacturing and […]

Gyros Protein Technologies to develop immunoassay kits for biotherapeutic impurity analysis using Cygnus Technologies’ proprietary reagents Uppsala, Sweden and Southport, N.C. ­– Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, and Cygnus Technologies, the leading assay and services provider for the detection and characterization of impurities […]

CAMBRIDGE, Mass – Ultivue has announced today the public launch of its UltiMapper™ portfolio of reagents enabling the highest throughput of whole-slide, protein biomarker spatial detection and analysis in tissue, at high level of multiplexing, using instrumentation and software solutions currently found in most Immuno-Histochemistry laboratories. With UltiMapper I/O reagents, Ultivue introduces a fully optimized, […]

Acquisition strengthens BioIVT’s transporter sciences capabilities and enables it to partner with customers on new drug applications and mechanistic studies related to transporters. Westbury, NY – BioIVT, a leading provider of research models and services for drug development, today announced that it has acquired Santa Clara, CA-based Optivia Biotechnology and its comprehensive portfolio of transporter assays, […]

Entopsis has licensed cutting-edge research tools from its new PCRopsis™ product line for the Chinese market to Beijing Wan Bridge Intelligent Technology. Backed by patent pending technologies, PCRopsis™’s three cost- and time-saving solutions forsample processing are expected to usher in a new direction for laboratory R&D.  Miami, Florida: Leading biotech R&D company Entopsis has recently licensed three state-of-the-art […]